View Scopus Profile

Jann N Sarkaria, MD

Professor, Rochester, MN, Radiation Oncology

EmailSarkaria.Jann@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

15385 Citations
57 Scopus h-Index
199 Article
16 Review article
2 Conference contribution
2 Comment/debate
More

2 results

Filter

2019
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (Journal of Neuro-Oncology, (2019), 143, 3, (573-581), 10.1007/s11060-019-03194-z)
Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In: Journal of neuro-oncology. 143, 3, p. 583 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
1 Scopus citations
2012

Erratum: Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients (Journal of Clinical Investigation (2012) 122, 1, (253-266) DOI: 10.1172/JCI59334)
Agnihotri, S., Gajadhar, A. S., Ternamian, C., Gorlia, T., Diefes, K. L., Mischel, P. S., Kelly, J., McGown, G., Thorncroft, M., Carlson, B. L., Sarkaria, J. N., Margison, G. P., Aldape, K., Hawkins, C., Hegi, M. & Guha, A., Feb 2012, In: Journal of Clinical Investigation. 122, 2, p. 782 1 p.
Research output: Contribution to journal › Comment/debate › peer-review